Open AccessAsenapine for schizophrenia and bipolar disorder: a review of the efficacy and safety profile for this newly approved sublingually absorbed second‐generation antipsychotic
Author(s) -
Citrome L.
Publication year - 2009
Publication title -
international journal of clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.756
H-Index - 98
eISSN - 1742-1241
pISSN - 1368-5031
DOI - 10.1111/j.1742-1241.2009.02228.x
Subject(s) - asenapine , medicine , clinical trial , antipsychotic , pharmacology , quetiapine , atypical antipsychotic , psychiatry , schizophrenia (object oriented programming)
To describe the efficacy and safety of asenapine for the treatment of schizophrenia and bipolar disorder.